| 1 |
Gao F, Han J, Jia L, He J, Wang Y, Chen M, Liu X, He X. MiR-30c facilitates natural killer cell cytotoxicity to lung cancer through targeting GALNT7. Genes Genomics 2023;45:247-60. [PMID: 36040682 DOI: 10.1007/s13258-022-01306-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 2 |
Su H, Liu K, Zhao Y, Shi F, Li Y, Wu J, Song Q, Sakai E. High Serum Squamous Cell Carcinoma Antigen Level Associated with Remission of Mild/Moderate Dysplasia of the Esophagus: A Nested Case–Control Study. Gastroenterology Research and Practice 2022;2022:1-6. [DOI: 10.1155/2022/2961337] [Reference Citation Analysis]
|
| 3 |
Eshraghi A, Riyahi MM, Ghaderi A, Fatemi MA, Eshraghi A, Fazilat‐panah D. Pure small cell neuroendocrine carcinoma of urinary bladder: A case report. Clinical Case Reports 2022;10. [DOI: 10.1002/ccr3.6156] [Reference Citation Analysis]
|
| 4 |
Hussain Y, Khan H, Alam W, Aschner M, Abdullah, Alsharif KF, Saso L. Flavonoids Targeting the mTOR Signaling Cascades in Cancer: A Potential Crosstalk in Anti-Breast Cancer Therapy. Oxid Med Cell Longev 2022;2022:4831833. [PMID: 35795855 DOI: 10.1155/2022/4831833] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Xu J, Cao W, Shao A, Yang M, Andoh V, Ge Q, Pan H, Chen K, Chiaradonna F. Metabolomics of Esophageal Squamous Cell Carcinoma Tissues: Potential Biomarkers for Diagnosis and Promising Targets for Therapy. BioMed Research International 2022;2022:1-24. [DOI: 10.1155/2022/7819235] [Reference Citation Analysis]
|
| 6 |
Tanaka O, Yagi N, Tawada M, Taniguchi T, Adachi K, Nakaya S, Makita C, Matsuo M. Hemostatic Radiotherapy for Gastric Cancer: MRI as an Alternative to Endoscopy for Post-Treatment Evaluation. J Gastrointest Cancer 2022. [PMID: 35604537 DOI: 10.1007/s12029-022-00837-9] [Reference Citation Analysis]
|
| 7 |
Mirzaei M, Eshraghi A, Ghoddoosi M, Fatemi MA, Eshraghi A, Suvvari TK, Fazilat‐panah D. Endometrial adenocarcinoma with bone metastasis: A case report. Clinical Case Reports 2022;10. [DOI: 10.1002/ccr3.5836] [Reference Citation Analysis]
|
| 8 |
Giotta Lucifero A, Luzzi S. Immune Landscape in PTEN-Related Glioma Microenvironment: A Bioinformatic Analysis. Brain Sci 2022;12. [PMID: 35448032 DOI: 10.3390/brainsci12040501] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 9 |
Mirzaei M, Eshraghi A, Ghoddoosi M, Fatemi MA, Eshraghi A, Shenavaei S, Fazilat‐panah D. Axillary lymph‐node metastases as the primary presentation of high‐grade serous ovarian carcinoma: A case report. Clinical Case Reports 2022;10. [DOI: 10.1002/ccr3.5724] [Reference Citation Analysis]
|
| 10 |
Xian Q, Zhu D, Zheng D. The Involvement of WDHD1 in the Occurrence of Esophageal Cancer as a Downstream Target of PI3K/AKT Pathway. Journal of Oncology 2022;2022:1-11. [DOI: 10.1155/2022/5871188] [Reference Citation Analysis]
|
| 11 |
Aledavood SA, Akbari Oryani M, Pishevar Feizabad Z. Tongue metastasis originated from esophageal squamous cell carcinoma: A case report. Clinical Case Reports 2022;10. [DOI: 10.1002/ccr3.5648] [Reference Citation Analysis]
|
| 12 |
Liu S, Wang Z, Ntim M, Han J, Jiang X, Fang C, Xu C, Zhang J, Hu W. Prediction of Survival Rate and Chemotherapy Effect by an Immune Score Model in Colorectal Cancer. BioMed Research International 2022;2022:1-13. [DOI: 10.1155/2022/8219701] [Reference Citation Analysis]
|
| 13 |
Lee CM, Kang MA, Bae JS, Park K, Yang YH, Lee J, Jang KY, Park SH. An in vitro study on anti-carcinogenic effect of remdesivir in human ovarian cancer cells via generation of reactive oxygen species. Hum Exp Toxicol 2022;41:9603271221089257. [PMID: 35417658 DOI: 10.1177/09603271221089257] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 14 |
Chen Y, He J, Liu D, Xiao J, Chen X, Tang H, Luo D, Shang C, Lian L, Peng J. Triplet versus doublet neoadjuvant chemotherapy regimens for locally advanced gastric cancer: a propensity score matching analysis. BMC Cancer 2021;21:1328. [PMID: 34903191 DOI: 10.1186/s12885-021-09093-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 15 |
Akbari H, Taghizadeh-Hesary F, Bahadori M. Mitochondria determine response to anti-programmed cell death protein-1 (anti-PD-1) immunotherapy: An evidence-based hypothesis. Mitochondrion 2022;62:151-8. [PMID: 34890822 DOI: 10.1016/j.mito.2021.12.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 16 |
Alizadeh B, Shaye Z, Badiea Z, Dehghanian P. Massive pericardial effusion as the first manifestation of childhood non-Hodgkin's lymphoma: A case report. Clin Case Rep 2021;9:e05105. [PMID: 34853684 DOI: 10.1002/ccr3.5105] [Reference Citation Analysis]
|
| 17 |
Yu X, Mao R, Feng W, Zhao Y, Qin J, Yang Y, Wang A, Shi Z. WISP3 suppresses ESCC progression by inhibiting the IGF-2-IGF1R-AKT signaling cascade. Exp Cell Res 2021;409:112871. [PMID: 34672999 DOI: 10.1016/j.yexcr.2021.112871] [Reference Citation Analysis]
|
| 18 |
Fazilat-Panah D, Ahmadi N, Moslemi D, Karimi M, Taji A, Dehghani M, Emadi Torghabeh A, Keshtpour Amlashi Z, Saghafi M, Fatemi MA. A case report of prostate adenocarcinoma with leptomeningeal carcinomatosis and intracerebral metastasis. Clin Case Rep 2021;9:e05000. [PMID: 34745620 DOI: 10.1002/ccr3.5000] [Reference Citation Analysis]
|
| 19 |
Fazilat-Panah D, Dehghani M, Ahmadi N, Karimi M, Soleimani Varaki S, Emadi Torghabeh A, Mahmoudi H, Keshtpour Amlashi Z, Saghafi M, Fatemi MA, Shokri Bousjin A. A case report of endometrial adenocarcinoma with leptomeningeal metastases. Clin Case Rep 2021;9:e04791. [PMID: 34584699 DOI: 10.1002/ccr3.4791] [Reference Citation Analysis]
|
| 20 |
Ouladdameshghi D, Eshraghi M, Shahhamzeh A, Riyah MM, Fatemi MA, Fazilat-Panah D, Dehghani M. A case report of mediastinal cavernous hemangioma. Clin Case Rep 2021;9:e04698. [PMID: 34466254 DOI: 10.1002/ccr3.4698] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 21 |
Novin K, Saneii M, Noori R, Shahin M, Berahman M, Hoveidamanesh S. Association Between Pathological Complete Response and Tumor Location in Patients with Rectal Cancer After Neoadjuvant Chemoradiotherapy, a Prospective Cohort Study. Int J Cancer Manag 2021;14. [DOI: 10.5812/ijcm.113135] [Reference Citation Analysis]
|
| 22 |
Ziaolhagh R, Sadrizadeh A, Shabany BP, Roudi AA. A case report of simultaneous medullary and papillary carcinoma of thyroid. Endocr Regul 2021;55:83-8. [PMID: 34020529 DOI: 10.2478/enr-2021-0010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 23 |
Zhang X, He Y, Gu H, Liu Z, Li B, Yang Y, Hao J, Hua R. Construction of a Nine-MicroRNA-Based Signature to Predict the Overall Survival of Esophageal Cancer Patients. Front Genet 2021;12:670405. [PMID: 34093662 DOI: 10.3389/fgene.2021.670405] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 24 |
Kong F, Shang Y, Diao X, Huang J, Liu H. Knockdown of NOLC1 Inhibits PI3K-AKT Pathway to Improve the Poor Prognosis of Esophageal Carcinoma. J Oncol 2021;2021:9944132. [PMID: 34046062 DOI: 10.1155/2021/9944132] [Reference Citation Analysis]
|
| 25 |
Zhou S, Guo Z, Zhou C, Zhang Y, Wang S. circ_NRIP1 is oncogenic in malignant development of esophageal squamous cell carcinoma (ESCC) via miR-595/SEMA4D axis and PI3K/AKT pathway. Cancer Cell Int 2021;21:250. [PMID: 33957921 DOI: 10.1186/s12935-021-01907-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 26 |
Feng Z, Feng Z, Han J, Cheng W, Su B, Mo J, Feng X, Feng S, Chen G, Huang P, Huang L, Cui Z. Antinociceptive Effects of Shenling Baizhu through PI3K-Akt-mTOR Signaling Pathway in a Mouse Model of Bone Metastasis with Small-Cell Lung Cancer. Evid Based Complement Alternat Med 2020;2020:4121483. [PMID: 32655659 DOI: 10.1155/2020/4121483] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 27 |
Jian J, Li S, Liu LZ, Zhen L, Yao L, Gan LH, Huang YQ, Fang N. XPD inhibits cell growth and invasion and enhances chemosensitivity in esophageal squamous cell carcinoma by regulating the PI3K/AKT signaling pathway. Int J Mol Med 2020;46:201-10. [PMID: 32377720 DOI: 10.3892/ijmm.2020.4593] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 28 |
Homaei Shandiz F, Fanipakdel A, Forghani MN, Javadinia SA, Mousapour Shahi E, Keramati A, Fazilat-panah D, Babaei MM. Clinical Efficacy and Side Effects of IORT as Tumor Bed Boost During Breast-Conserving Surgery in Breast Cancer Patients Following Neoadjuvant Chemotherapy. Indian J Gynecol Oncolog 2020;18. [DOI: 10.1007/s40944-020-00389-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 29 |
Fazilat-Panah D, Vakili Ahrari Roudi S, Keramati A, Fanipakdel A, Sadeghian MH, Homaei Shandiz F, Shahidsales S, Javadinia SA. Changes in Cytokeratin 18 during Neoadjuvant Chemotherapy of Breast Cancer: A Prospective Study. Iran J Pathol 2020;15:117-26. [PMID: 32215027 DOI: 10.30699/ijp.2020.116238.2261] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 30 |
Parekh B, Ghadlyalpatil N, Chandarana EV, Hingmire SS, Sumant G, Agarwala V, Tiwari A, Bhattacharyya GS, Parikh PM. Immunotherapy in esophageal cancer-An update. Int J Mol and ImmuOncol 2019;4:34-40. [DOI: 10.25259/ijmio-11-2019] [Reference Citation Analysis]
|
| 31 |
Bahrami A, Khazaei M, Avan A. Long Non-coding RNA and microRNAs as Novel Potential Biomarker and Therapeutic Target in the Treatment of Gastrointestinal Cancers. Curr Pharm Des 2018;24:4599-600. [PMID: 30924419 DOI: 10.2174/138161282439190314091937] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 32 |
Aledavood SA, Anvari K, Shahidsales S, Hosseini S, Emadi Torghabeh A, Masudian M. Post-neoadjuvant chemoradiotherapy tumor resectability following induction chemotherapy in locally advanced proximal gastric and adenocarcinoma of the esophagogastric junction: A clinical trial. Caspian J Intern Med 2021;12:256-62. [PMID: 34221274 DOI: 10.22088/cjim.12.3.256] [Reference Citation Analysis]
|
